We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Freds Inc | NASDAQ:FRED | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.1265 | 0.1172 | 0.1205 | 0 | 01:00:00 |
From Aug 2019 to Aug 2024
By Bowdeya Tweh
ACQUIRER: CVS Health Corp. (CVS), $62.79 billion market cap
SELLER: Fred's Inc. (FRED), $62 million market cap
TARGET: EntrustRx, Fred's specialty-pharmacy unit
PRICE: $40 million, plus an amount equal to inventory value
STATUS: Under agreement
RATIONALE: Fred's has been working to sell noncore assets and Interim Chief Executive Joe Anto said in prepared remarks that proceeds will allow the company to "pay down a significant portion of our debt and also be used for general corporate purposes."
CLOSING: Expected to close by the end of May.
STOCK: Shares in Fred's rose 14% to $1.90 in after-hours trading.
Write to Bowdeya Tweh at bowdeya.tweh@wsj.com
(END) Dow Jones Newswires
May 07, 2018 16:44 ET (20:44 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Freds Chart |
1 Month Freds Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
